Clinical Trial Update: Accell Evo3™ Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion [NA]

View source ↗

Summary

A completed clinical trial evaluating Accell Evo3 Demineralized Bone Matrix in instrumented lumbar spine fusion; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Changes of Spine
• Spinal Stenosis

Drugs mentioned

• Accell Evo3 Demineralized Bone Matrix (demineralized bone matrix)

Snippet

Sponsor: SeaSpine, Inc. | Conditions: Degenerative Changes, Stenosis | NA | Status: COMPLETED | Results posted: 2020-02-18